Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder

Psychiatry Research

Volumn 178, Issue 2, 2010, Pages 374-380

  Gray, Laura J ^a,b   Dean, Brian ^a,b,c   Kronsbein, Helena C ^a,d   Robinson, Phillip J ^e   Scarr, Elizabeth ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Synuclein; Dynamin; NCAM; Psychiatric disorders; SNAP 25; Synapse; Synaptophysin; Syntaxin; VAMP

Indexed keywords

ALPHA SYNUCLEIN; DYNAMIN I; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; PRESYNAPTIC PROTEIN; SYNAPTOBREVIN; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR I DISORDER; BRAIN CORTEX; CONTROLLED STUDY; HUMAN; MEMBRANE FUSION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

ADULT; AGED; BIPOLAR DISORDER; CEREBRAL CORTEX; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURAL CELL ADHESION MOLECULES; QA-SNARE PROTEINS; R-SNARE PROTEINS; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; SYNAPTOPHYSIN; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 77953809344     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.07.012     Document Type: Article

References (75)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
2. Adler C.M., Holland S.K., Schmithorst V., Tuchfarber M.J., Strakowski S.M. Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disorders 2004, 6:540-549.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
4. Azmitia E.C. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Research Bulletin 2001, 56:413-424.
5. Barbeau D., Liang J., Robitaille Y., Quirion R., Srivastava L. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proceedings of the National Academy of Sciences 1995, 92:2785-2789.
6. Barr A.M., Young C.E., Phillips A.G., Honer W.G. Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. International Journal of Neuropsychopharmacology 2006, 9:457-463.
7. Beasley C.L., Honer W.G., Bergmann K., Falkai P., Lutjohann D., Bayer T.A. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disorders 2005, 7:449-455.
8. Benfenati F., Onofri F., Giovedi S. Protein-protein interactions and protein modules in the control of neurotransmitter release. Philosophical Transactions of the Royal Society of London, B: Biological Sciences 1999, 354:243-257.
9. Blumberg H.P., Charney D.S., Krystal J.H. Frontotemporal neural systems in bipolar disorder. Seminars in Clinical Neuropsychiatry 2002, 7:243-254.
10. Brunger A.T. Structural insights into the molecular mechanism of Ca(2+)-dependent exocytosis. Current Opinion in Neurobiology 2000, 10:293-302.
11. Buttner B., Reutter W., Horstkorte R. Cytoplasmic domain of NCAM 180 reduces NCAM-mediated neurite outgrowth. Journal of Neuroscience Resarch 2004, 75:854-860.
12. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.L., Orrison B., Chen A., Ellis C.E., Paylor R., Lu B., Nussbaum R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. Journal of Neuroscience 2002, 22:8797-8807.
13. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends in Neuroscience 1998, 21:249-254.
14. Cordeiro M.L., Umbach J.A., Gundersen C.B. Lithium ions up-regulate mRNAs encoding dense-core vesicle proteins in nerve growth factor-differentiated PC12 cells. Journal of Neurochemistry 2000, 75:2622-2625.
15. Cotman C.W., Hailer N.P., Pfister K.K., Soltesz I., Schachner M. Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations?. Progress in Neurobiology 1998, 55:659-669.
16. Dean B. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia. Australian and New Zealand Journal of Psychiatry 2000, 34:560-569.
17. Dean B., Scarr E., Pavey G., Copolov D. Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder. Journal of Affective Disorders 2003, 75:65-69.
18. Dean B., Keriakous D., Thomas E., Scarr E. Understanding the pathology of schizophrenia: the impact of high-throughput screening of the genome and proteome in postmortem CNS. Current Psychiatry Reviews 2005, 1:1-19.
19. Dityatev A., Dityateva G., Schachner M. Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM. Neuron 2000, 26:207-217.
20. Doherty P., Fazeli M.S., Walsh F.S. The neural cell adhesion molecule and synaptic plasticity. Journal of Neurobiology 1995, 26:437-446.
21. Eastwood S.L. The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?. International Reviews of Neurobiology 2004, 59:47-72.
22. Eastwood S.L., Harrison P.J. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Research Bulletin 2001, 55:569-578.
23. Eastwood S.L., Cairns N.J., Harrison P.J. Synaptophysin gene expression in schizophreniaInvestigation of synaptic pathology in the cerebral cortex. British Journal of Psychiatry 2000, 176:236-242.
24. Edelmann L., Hanson P.I., Chapman E.R., Jahn R. Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. The EMBO Journal 1995, 14:224-231.
25. Farrer C., Franck N., Frith C.D., Decety J., Georgieff N., d'Amato T., Jeannerod M. Neural correlates of action attribution in schizophrenia. Psychiatry Research: Neuroimaging 2004, 131:31-44.
26. Fatemi S.H., Earle J.A., Stary J.M., Lee S., Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. Neuroreport 2001, 12:3257-3262.
27. Foster P. Neuroleptic equivalence. Pharmaceutical Journal 1999, 243:431-432.
28. Fuster J.M. Frontal lobe and cognitive development. Journal of Neurocytology 2002, 31:373-385.
29. Gabriel S.M., Haroutunian V., Powchik P., Honer W.G., Davidson M., Davies P., Davis K.L. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Archives of General Psychiatry 1997, 54:559-566.
30. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity [corrected and republished article originally appeared in Archives of General Psychiatry 1997 Jul;54(7):660-669]. Archives of General Psychiatry 1997, 54:943-952.
31. Glantz L.A., Austin M.C., Lewis D.A. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 2000, 48:389-397.
32. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophrenia Bulletin 1997, 23:437-458.
33. Hepp R., Langley K. SNAREs during development. Cell Tissue Research 2001, 305:247-253.
34. Hill C., Keks N., Roberts S., Opeskin K., Dean B., Copolov D. Diagnostic Instrument for Brain Studies 1999, Mental Health Research Institute, Melbourne.
35. Hoffman K.B. The relationship between adhesion molecules and neuronal plasticity. Cellular and Molecular Neurobiology 1998, 18:461-475.
36. Honer W.G., Falkai P., Young C., Wang T., Xie J., Bonner J., Hu L., Boulianne G.L., Luo Z., Trimble W.S. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997, 78:99-110.
37. Honer W.G., Falkai P., Chen C., Arango V., Mann J.J., Dwork A.J. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 1999, 91:1247-1255.
38. Honer W.G., Falkai P., Bayer T.A., Xie J., Hu L., Li H.Y., Arango V., Mann J.J., Dwork A.J., Trimble W.S. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cerebral Cortex 2002, 12:349-356.
39. Jorgensen O.S. Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochemistry Research 1995, 20:533-547.
40. Kahle P.J., Haass C., Kretzschmar H.A., Neumann M. Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases. Journal of Neurochemistry 2002, 82:449-457.
41. Kaplan B., Ratner V., Haas E. Alpha-synuclein: its biological function and role in neurodegenerative diseases. Journal of Molecular Neuroscience 2003, 20:83-92.
42. Karson C.N., Mrak R.E., Schluterman K.O., Sturner W.Q., Sheng J.G., Griffin W.S. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Molecular Psychiatry 1999, 4:39-45.
43. Kingsbury A.E., Foster O.J., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Research, Molecular Brain Research 1995, 28:311-318.
44. Lin R.C., Scheller R.H. Mechanisms of synaptic vesicle exocytosis. Annual Review of Cell and Developmental Biology 2000, 16:19-49.
45. Liu S., Ninan I., Antonova I., Battaglia F., Trinchese F., Narasanna A., Kolodilov N., Dauer W., Hawkins R.D., Arancio O. Alpha-synuclein produces a long-lasting increase in neurotransmitter release. The EMBO Journal 2004, 23:4506-4516.
46. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives of General Psychiatry 2000, 57:637-648.
47. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28:53-67.
48. Monks P.J., Thompson J.M., Bullmore E.T., Suckling J., Brammer M.J., Williams S.C., Simmons A., Giles N., Lloyd A.J., Harrison C.L., Seal M., Murray R.M., Ferrier I.N., Young A.H., Curtis V.A. A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disorders 2004, 6:550-564.
49. Mukaetova-Ladinska E.B., Hurt J., Honer W.G., Harrington C.R., Wischik C.M. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neuroscience Letters 2002, 317:161-165.
50. Murphy D.D., Rueter S.M., Trojanowski J.Q., Lee V.M.-Y. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. Journal of Neuroscience 2000, 20:3214-3220.
51. Owe-Larsson B., Berglund M., Kristensson K., Garoff H., Larhammar D., Brodin L., Low P. Perturbation of the synaptic release machinery in hippocampal neurons by overexpression of SNAP-25 with the Semliki Forest virus vector. European Journal of Neurosci 1999, 11:1981-1987.
52. Polo-Parada L., Bose C.M., Plattner F., Landmesser L.T. Distinct roles of different neural cell adhesion molecule (NCAM) isoforms in synaptic maturation revealed by analysis of NCAM 180kDa isoform-deficient mice. Journal of Neuroscience 2004, 24:1852-1864.
53. Robinson P.J., Sontag J.M., Liu J.P., Fykse E.M., Slaughter C., McMahon H., Sudhof T.C. Dynamin GTPase regulated by protein kinase C phosphorylation in nerve terminals. Nature 1993, 365:163-166.
54. Scarr E., Gray L., Keriakous D., Robinson P., Dean B. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disorders 2006, 8:133-143.
55. Schmid R.S., Graff R.D., Schaller M.D., Chen S., Schachner M., Hemperly J.J., Maness P.F. NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells. Journal of Neurobiology 1999, 38:542-558.
56. Schuster T., Krug M., Hassan H., Schachner M. Increase in proportion of hippocampal spine synapses expressing neural cell adhesion molecule NCAM180 following long-term potentiation. Journal of Neurobiology 1998, 37:359-372.
57. Selemon L.D., Rajkowska G. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Current Molecular Medicine 2003, 3:427-436.
58. Sobczak S., Honig A., van Duinen M.A., Riedel W.J. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disorders 2002, 4:347-356.
59. Sokolov B.P., Tcherepanov A.A., Haroutunian V., Davis K.L. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biological Psychiatry 2000, 48:184-196.
60. Strakowski S.M., DelBello M.P., Adler C., Cecil D.M., Sax K.W. Neuroimaging in bipolar disorder. Bipolar Disorders 2000, 2:148-164.
61. Sudhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 1995, 375:645-653.
62. Sullivan P.F., Keefe R.S.E., Lange L.A., Lange E.M., Stroup T.S., Lieberman J., Maness P.F. NCAM1 and neurocognition in schizophrenia. Biological Psychiatry 2007, 61:902-910.
63. Tan T.C., Valova V.A., Malladi C.S., Graham M.E., Berven L.A., Jupp O.J., Hansra G., McClure S.J., Sarcevic B., Boadle R.A., Larsen M.R., Cousin M.A., Robinson P.J. Cdk5 is essential for synaptic vesicle endocytosis. Nature Cell Biolog 2003, 5:701-710.
64. Thompson P.M., Sower A.C., Perrone-Bizzozero N.I. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biological Psychiatry 1998, 43:239-243.
65. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A 1979, 76:4350-4354.
66. Vawter M.P., Cannon-Spoor H.E., Hemperly J.J., Hyde T.M., VanderPutten D.M., Kleinman J.E., Freed W.J. Abnormal expression of cell recognition molecules in schizophrenia. Experimental Neurology 1998, 149:424-432.
67. Vawter M.P., Thatcher L., Usen N., Hyde T.M., Kleinman J.E., Freed W.J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Molecular Psychiatry 2002, 7:571-578.
68. Washbourne P., Thompson P.M., Carta M., Costa E.T., Mathews J.R., Lopez-Bendito G., Molnar Z., Becher M.W., Valenzuela C.F., Partridge L.D., Wilson M.C. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nature Neuroscience 2002, 5:19-26.
69. Weiss E.M., Siedentopf C., Golaszewski S., Mottaghy F.M., Hofer A., Kremser C., Felber S., Fleischhacker W.W. Brain activation patterns during a selective attention test - a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophrenia. Psychiatry Research: Neuroimaging 2007, 154:31-40.
70. Wheal H.V., Chen Y., Mitchell J., Schachner M., Maerz W., Wieland H., van Rossum D., Kirsch J. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Progress in Neurobiology 1998, 55:611-640.
71. Yamada M., Takahashi K., Tsunoda M., Nishioka G., Kudo K., Ohata H., Kamijima K., Higuchi T., Momose K. Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics Journal 2002, 2:377-382.
72. Young L.T., Warsh J.J., Kish S.J., Shannak K., Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biological Psychiatry 1994, 35:121-127.
73. Young C.E., Arima K., Xie J., Hu L., Beach T.G., Falkai P., Honer W.G. SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cerebral Cortex 1998, 8:261-268.
74. Zedkova L., Woodward N.D., Harding I., Tibbo P.G., Purdon S.E. Procedural learning in schizophrenia investigated with functional magnetic resonance imaging. Schizophrenia Research 2006, 88:198-207.
75. Zhou S.-Y., Suzuki M., Takahashi T., Hagino H., Kawasaki Y., Matsui M., Seto H., Kurachi M. Parietal lobe volume deficits in schizophrenia spectrum disorders. Schizophrenia Research 2007, 89:35-48.